Age‐standardisation when target setting and auditing performance of Down syndrome screening programmes
- 24 November 2004
- journal article
- research article
- Published by Wiley in Prenatal Diagnosis
- Vol. 24 (11) , 851-856
- https://doi.org/10.1002/pd.990
Abstract
Objective To describe and illustrate a method of setting Down syndrome screening targets and auditing performance that allows for differences in the maternal age distribution. Methods A reference population was determined from a Gaussian model of maternal age. Target detection and false‐positive rates were determined by standard statistical modelling techniques, except that the reference population rather than an observed population was used. Second‐trimester marker parameters were obtained for Down syndrome from a large meta‐analysis, and for unaffected pregnancies from the combined results of more than 600 000 screens in five centres. Audited detection and false‐positive rates were the weighted average of the rates in five broad age groups corrected for viability bias. Weights were based on the age distributions in the reference population. Results Maternal age was found to approximate reasonably well to a Gaussian distribution with mean 27 years and standard deviation 5.5 years. Depending on marker combination, the target detection rates were 59 to 64% and false‐positive rate 4.2 to 5.4% for a 1 in 250 term cut‐off; 65 to 68% and 6.1 to 7.3% for 1 in 270 at mid‐trimester. Among the five centres, the audited detection rate ranged from 7% below target to 10% above target, with audited false‐positive rates better than the target by 0.3 to 1.5%. Conclusion Age‐standardisation should help to improve screening quality by allowing for intrinsic differences between programmes, so that valid comparisons can be made. Copyright © 2004 John Wiley & Sons, Ltd.Keywords
This publication has 8 references indexed in Scilit:
- Down syndrome fetal loss rate in early pregnancyPrenatal Diagnosis, 1999
- Second trimester prenatal screening for Down's syndrome using alpha‐fetoprotein and free beta hCG: a seven year reviewBJOG: An International Journal of Obstetrics and Gynaecology, 1999
- A Demographic Approach to the Assessment of Down Syndrome Screening PerformancePrenatal Diagnosis, 1997
- Improved parameters for risk estimation in Down's syndrome screeningPrenatal Diagnosis, 1995
- Impact of a Regional Screening Programme Using Maternal Serum a Fetoprotein (AFP) and Human Chorionic Gonadotrophin (hCG) on the Birth Incidence of Down's Syndrome in the West of ScotlandJournal of Medical Screening, 1994
- Second‐trimester maternal serum screening using alpha‐fetoprotein, human chorionic gonadotrophin, and unconjugated oestriol: Experience of a regional programmePrenatal Diagnosis, 1994
- Model‐based screening by risk with application to down's syndromeStatistics in Medicine, 1992
- Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha‐fetoprotein levelBJOG: An International Journal of Obstetrics and Gynaecology, 1987